Filing Details
- Accession Number:
- 0001104659-15-084747
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-14 21:44:57
- Reporting Period:
- 2015-12-10
- Filing Date:
- 2015-12-14
- Accepted Time:
- 2015-12-14 21:44:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1410939 | Ophthotech Corp. | OPHT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1252522 | Nicholas Galakatos | C/O Clarus Ventures, Llc 101 Main Street, Suite 1210 Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-12-10 | 533 | $63.90 | 9,151 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-12-10 | 1,467 | $64.63 | 7,684 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-12-10 | 267 | $63.91 | 5,678 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2015-12-10 | 733 | $64.63 | 4,945 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
Footnotes
- The sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2015.
- The sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by AAG Peakham LLC on September 10, 2015.
- Shares are held by AAG Peakham LLC of which the Reporting Person is a manager.
- These shares were disposed of in multiple transactions on December 10, 2015 at actual sales prices ranging from $63.31 to $64.30 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- These shares were disposed of in multiple transactions on December 10, 2015 at actual sales prices ranging from $64.31 to $65.03 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- These shares were disposed of in multiple transactions on December 10, 2015 at actual sales prices ranging from $63.31 to $64.30 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- These shares were disposed of in multiple transactions on December 10, 2015 at actual sales prices ranging from $64.31 to $65.03 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.